サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540995

神経血管デバイス市場レポート：製品、用途、エンドユーザー、地域別、2024～2032年

Neurovascular Devices Market Report by Product, Application (Ischemic Stroke, Aneurysm, Arteriovenous Malformation and Fistulas, Stenosis, and Others), End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.12円
神経血管デバイス市場レポート：製品、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経血管デバイス市場規模は2023年に29億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに46億米ドルに達し、2024～2032年の間に5.14％の成長率（CAGR）を示すと予測しています。技術の進歩、神経血管障害の有病率の増加、低侵襲治療を求める高齢者人口の増加、医療専門家と研究機関の協力的な取り組みが市場の成長を促進しています。

神経血管デバイスは、脳や脊髄内の血管や神経系に影響を及ぼす状態を診断・治療するために設計された医療器具です。安全性と有効性を確保するため、高度な材料と精密工学技術を用いて慎重に作られています。患者の不快感や入院期間、合併症を軽減する低侵襲の手技を可能にすることで、大きな利点をもたらしています。神経血管器具は、動脈瘤、動静脈奇形、虚血性脳卒中などのさまざまな症状への対応に幅広く応用されています。神経血管デバイスタイプには、ステント、塞栓コイル、フローダイバータ、カテーテルなどがあります。ステントは血管の完全性をサポートし、塞栓コイルは動脈瘤を治療するために血流を遮断するのに役立ちます。フローダイバータは弱った血管部分から血流を遠ざけるために使用され、カテーテルは患部への直接治療を可能にします。

世界の神経血管デバイス市場は、特に神経血管インターベンションセグメントにおける医療機器の急速な技術進歩の影響を受けています。さらに、脳卒中、動脈瘤、動静脈奇形などの疾患の有病率が上昇していることから、革新的で効果的な治療アプローチの需要が必要となり、市場の拡大に拍車をかけています。さらに、世界の高齢者人口の増加と神経血管疾患に対する意識の高まり、低侵襲手術の利用可能性が相まって、市場の推進力となっています。これに伴い、世界の医療インフラの開拓も神経血管治療へのアクセス向上に寄与しており、市場の成長をさらに促進しています。

神経血管デバイス市場動向/促進要因：

技術革新がイノベーションを促進

世界の神経血管デバイスの領域では、技術進歩の継続的な急増が極めて重要な推進力となっています。医療機器の技術革新は神経血管介入に革命をもたらし、さまざまな神経血管障害に新たな治療の道を提示しています。3Dプリンティング、高度な画像処理技術、低侵襲手術などの最先端技術は、患者ケアの風景を塗り替えました。これらの技術革新は、より正確な診断と治療を可能にし、患者の転帰を向上させ、リスクを軽減します。さらに、神経血管インターベンションにロボット工学と人工知能を統合することで、手技を最適化し、個別化された治療を保証する計り知れない可能性が秘められています。研究開発の努力が続く中、技術進歩の絶え間ない追求が神経血管デバイス市場の勢いを加速させ、医療技術革新の最前線に位置することを確立しています。

神経血管障害の有病率の上昇

世界の神経血管デバイス市場の上昇軌道は、神経血管障害の有病率の上昇と本質的に関連しています。脳卒中、動脈瘤、動静脈奇形などの課題は、世界規模で重大な健康問題を引き起こしています。人口の高齢化とライフスタイルや危険因子の変化が、これらの疾患の発生率を高めています。このような症例の急増により、正確な診断、治療、治療後のモニタリングのための効果的で高度な神経血管デバイスの開発が必要とされています。特に、患者の不快感を軽減し、回復までの時間を短縮できる低侵襲手術の需要が目立ってきています。その結果、市場はこのニーズの高まりに革新的な機器とソリューションで対応し、患者の転帰と生活の質の向上に不可欠な参入企業としての地位を再確認しています。

高齢者人口と低侵襲治療へのアクセシビリティ

高齢者人口は、世界の神経血管デバイス市場拡大の重要な推進力となっています。高齢化により神経血管障害に罹患しやすくなり、包括的かつ低侵襲な治療オプションへの需要が高まっています。高齢者は、身体的ストレスや回復時間を最小限に抑える侵襲性の低い手技を好むことが多いです。その結果、メーカー各社はこの患者グループに合わせた機器の開発に注力し、安全性と有効性を確保しています。低侵襲治療が利用できるようになれば、患者のコンプライアンスが向上するだけでなく、医療業界では費用対効果が高く効率的な治療が重視されるようになります。高齢化社会のニーズと市場の製品との間のこの一致は、進化する医療需要に対応する神経血管機器セクターの重要な役割を確固たるものにしています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の神経血管デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 脳塞栓術と動脈瘤コイル塞栓術
    • 市場動向
    • 主要セグメント
      • 塞栓コイル
      • フローダイバータ
      • 液体塞栓剤
    • 市場予測
  • 脳血管形成術とステント留置システム
    • 市場動向
    • 主要セグメント
      • 頸動脈ステント
      • 塞栓保護デバイス
    • 市場予測
  • 神経血栓除去デバイス
    • 市場動向
    • 主要セグメント
      • 血栓除去デバイス
      • 吸引デバイス
      • 血管スネア
    • 市場予測
  • サポートデバイス
    • 市場動向
    • 主要セグメント
      • マイクロカテーテル
      • マイクロガイドワイヤー
    • 市場予測

第7章 市場内訳：用途別

  • 虚血性脳卒中
  • 動脈瘤
  • 動静脈奇形と瘻孔（AVM）
  • 狭窄
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Acandis GmbH
    • Asahi Intecc Co. Ltd.
    • Imperative Care Inc.
    • Integer Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Penumbra Inc.
    • Perflow Medical Ltd.
    • Rapid Medical
    • Stryker Corporation
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Neurovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurovascular Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neurovascular Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Neurovascular Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Neurovascular Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Neurovascular Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Neurovascular Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Neurovascular Devices (Neurothrombectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Neurovascular Devices (Neurothrombectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Neurovascular Devices (Support Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Neurovascular Devices (Support Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Neurovascular Devices (Ischemic Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Neurovascular Devices (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Neurovascular Devices (Aneurysm) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Neurovascular Devices (Aneurysm) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Neurovascular Devices (Stenosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Neurovascular Devices (Stenosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Neurovascular Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Neurovascular Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Neurovascular Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Neurovascular Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Neurovascular Devices (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Neurovascular Devices (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Neurovascular Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Neurovascular Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Neurovascular Devices Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Neurovascular Devices Industry: SWOT Analysis
  • Figure 84: Global: Neurovascular Devices Industry: Value Chain Analysis
  • Figure 85: Global: Neurovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurovascular Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Neurovascular Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Neurovascular Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Neurovascular Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Neurovascular Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Neurovascular Devices Market: Competitive Structure
  • Table 7: Global: Neurovascular Devices Market: Key Players
目次
Product Code: SR112024A6128

The global neurovascular devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032. Technological advancements, increasing prevalence of neurovascular disorders, rising geriatric population seeking minimally invasive treatments, and collaborative efforts among healthcare professionals and research institutions are augmenting the market growth.

Neurovascular devices are medical tools designed to diagnose and treat conditions affecting the blood vessels and nervous system within the brain and spinal cord. They are carefully crafted using advanced materials and precision engineering techniques to ensure their safety and efficacy. They offer significant advantages by enabling minimally invasive procedures that reduce patient discomfort, hospitalization times, and complications. Neurovascular devices find extensive application in addressing various conditions, such as aneurysms, arteriovenous malformations, and ischemic strokes. The types of neurovascular devices include stents, embolic coils, flow diverters, and catheters. Stents support blood vessel integrity, while embolic coils help block blood flow to treat aneurysms. Flow diverters are used to redirect blood flow away from weakened vessel areas, and catheters enable the delivery of treatments directly to affected areas.

The global neurovascular devices market is influenced by rapid technological advancements in medical devices, particularly in the field of neurovascular interventions. Moreover, the rising prevalence of conditions such as strokes, aneurysms, and arteriovenous malformations necessitates the demand for innovative and effective treatment approaches, fueling the market's expansion. Additionally, the increasing geriatric population worldwide, coupled with a growing awareness of neurovascular diseases and the availability of minimally invasive procedures, propels the market forward. In line with this, the healthcare infrastructure development globally also contributes to enhanced accessibility to neurovascular treatments, further propelling market growth.

Neurovascular Devices Market Trends/Drivers:

Technological advancements driving innovation

In the realm of global neurovascular devices, a pivotal driver is the continuous surge in technological advancements. Innovations in medical devices have revolutionized neurovascular interventions, presenting novel treatment avenues for various neurovascular disorders. Cutting-edge technologies such as 3D printing, advanced imaging techniques, and minimally invasive procedures have reshaped the landscape of patient care. These innovations enable more precise diagnosis and treatment, enhancing patient outcomes and reducing risks. Moreover, the integration of robotics and artificial intelligence into neurovascular interventions holds immense potential for optimizing procedures and ensuring personalized treatments. As research and development efforts persist, the relentless pursuit of technological progress fuels the momentum of the neurovascular devices market, establishing it at the forefront of medical innovation.

Rising prevalence of neurovascular disorders

The upward trajectory of the global neurovascular devices market is intrinsically linked to the rising prevalence of neurovascular disorders. Conditions such as strokes, aneurysms, and arteriovenous malformations pose significant health challenges on a global scale. The aging population, coupled with changing lifestyles and risk factors, has contributed to a higher incidence of these disorders. This surge in cases necessitates the development of effective and advanced neurovascular devices for accurate diagnosis, treatment, and post-treatment monitoring. The demand for minimally invasive procedures has particularly gained prominence due to their reduced patient discomfort and quicker recovery times. Consequently, the market responds to this growing need with innovative devices and solutions, reaffirming its position as a vital player in improving patient outcomes and quality of life.

Geriatric population and accessibility to minimally invasive treatments

The geriatric demographic stands as a significant driver in the expansion of the global neurovascular devices market. With the aging population becoming more susceptible to neurovascular disorders, the demand for comprehensive and minimally invasive treatment options escalates. Older individuals often prefer less invasive procedures that minimize physical stress and recovery times. As a result, manufacturers focus on developing devices tailored to this patient group, ensuring their safety and efficacy. The availability of minimally invasive treatments not only improves patient compliance but also addresses the healthcare industry's ongoing emphasis on cost-effective and efficient interventions. This alignment between the needs of the aging population and the market's offerings solidifies the neurovascular devices sector's crucial role in catering to evolving healthcare demands.

Neurovascular Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neurovascular devices market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Cerebral Embolization and Aneurysm Coiling Devices

Embolic Coils

Flow Diverters

Liquid Embolic Agents

Cerebral Angioplasty and Stenting Systems

Carotid Artery Stents

Embolic Protection Devices

Neurothrombectomy Devices

Clot Retrieval Devices

Suction Devices

Vascular Snares

Support Devices

Micro Catheters

Micro Guidewires

Cerebral embolization and aneurysm coiling devices dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cerebral embolization and aneurysm coiling devices (embolic coils, flow diverters, and liquid embolic agents), cerebral angioplasty and stenting systems (carotid artery stents and embolic protection devices), neurothrombectomy devices (clot retrieval devices, suction devices, and vascular snares), and support devices (micro catheters and micro guidewires). According to the report, cerebral embolization and aneurysm coiling devices represented the largest segment.

The growth of the cerebral embolization and aneurysm coiling devices segment can be attributed to several key factors that collectively shape its trajectory. Technological advancements play a pivotal role, with continuous innovations enhancing the efficacy and safety of these devices. As medical technologies evolve, cerebral embolization and aneurysm coiling devices are becoming more sophisticated, allowing for more precise interventions and improved patient outcomes. Moreover, the increasing incidence of cerebral aneurysms and related disorders drives demand for advanced treatment options, fostering the adoption of coiling devices. Minimally invasive procedures have gained traction due to their reduced patient discomfort and quicker recovery times, further fueling the segment's growth. Additionally, rising awareness among healthcare professionals and patients regarding the benefits of early intervention and minimally invasive techniques contributes to expanded usage of these devices.

Breakup by Application:

Ischemic Stroke

Aneurysm

Arteriovenous Malformation and Fistulas (AVM)

Stenosis

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes ischemic stroke, aneurysm, arteriovenous malformation and fistulas (AVM), stenosis, and others.

Within the ischemic stroke segment, the surge in global incidences, especially among the aging population, fuels demand for advanced interventions. Technological strides enable swift diagnoses and targeted treatments, while thrombectomy procedures and clot retrieval devices enhance patient outcomes. The aneurysm segment thrives due to surging awareness of risks, spurring demand for effective treatments. Innovations like flow diverters and collaboration among medical professionals amplify growth. Similarly, the arteriovenous malformation and fistulas (AVM) segment benefits from precise imaging, minimally invasive methods, and collaborative efforts. The stenosis segment, on the other hand, is driven by the need for advanced interventions and technological progress and early interventions. Furthermore, the others segment evolves through tailored technological solutions, collaborative research, and growing global awareness, underscoring its contribution to the neurovascular devices market's overall expansion.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Clinics

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, clinics, and others. According to the report, hospitals represented the largest segment.

The growth of the hospitals segment within the neurovascular devices market can be attributed to the advancements in medical technology that have significantly enhanced the quality of patient care provided by hospitals. Cutting-edge diagnostic tools, surgical instruments, and treatment methods enable hospitals to offer state-of-the-art medical services, attracting patients seeking the latest and most effective treatments. Additionally, the increasing prevalence of chronic diseases and the aging population drives the demand for specialized medical care, further boosting hospital growth. Moreover, the role of hospitals as centers of medical expertise and comprehensive care fosters their growth. Patients often prefer hospitals for their ability to provide a wide range of medical services under one roof, including diagnostics, surgery, rehabilitation, and specialized treatments. This integrated approach enhances patient convenience and healthcare outcomes, positioning hospitals as trusted destinations for healthcare needs. Furthermore, strategic partnerships and collaborations between hospitals and pharmaceutical companies, medical device manufacturers, and research institutions fuel growth.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurovascular devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the neurovascular devices market in North America is underpinned by a robust healthcare infrastructure, coupled with advanced medical technology. The region's strong focus on research and development fosters the creation of cutting-edge devices, driving the market's expansion. In line with this, the increasing prevalence of neurovascular disorders, attributed to factors such as lifestyle changes and an aging population, elevates the demand for effective treatment solutions. Furthermore, heightened awareness of the importance of early diagnosis and intervention among both healthcare professionals and the general public contributes to market growth. Additionally, strategic collaborations between industry players, research institutions, and healthcare providers propel the development of groundbreaking neurovascular devices. Regulatory bodies' support for swift approval processes and the region's favorable reimbursement policies facilitates market accessibility. The presence of skilled healthcare professionals and a patient-centric approach further accentuate the adoption of neurovascular interventions.

Competitive Landscape:

The competitive landscape of the global neurovascular devices market showcases a dynamic and evolving environment driven by innovation and strategic initiatives. Industry players are engaged in continuous research and development efforts to introduce advanced devices that cater to the increasing demand for effective neurovascular interventions. Collaborative ventures between manufacturers, research institutions, and healthcare providers amplify the development of cutting-edge solutions. Mergers and acquisitions within the market enhance product portfolios, distribution networks, and market reach. Moreover, the emphasis on regulatory compliance and adherence to quality standards ensures the delivery of safe and efficacious devices.

As the market gains traction, the competitive landscape is also influenced by factors such as pricing strategies, product differentiation, and customer support. Companies seek to establish themselves as thought leaders by actively participating in conferences, publishing research findings, and engaging in knowledge-sharing activities. This approach aims to position them as trusted experts in the neurovascular domain. In this ever-evolving arena, the competitive landscape remains a dynamic interplay of innovation, strategic collaborations, and efforts to establish a distinct market presence.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Acandis GmbH

Asahi Intecc Co. Ltd.

Imperative Care Inc.

Integer Holdings Corporation

Johnson & Johnson

Medtronic plc

MicroPort Scientific Corporation

Penumbra Inc.

Perflow Medical Ltd.

Rapid Medical

Stryker Corporation

Terumo Corporation

Recent Developments:

In July 2023, Rapid Medical announced new clinical data demonstrating the "significant advantages" of its novel Comaneci embolisation assist device to treat ruptured wide-neck intracranial aneurysms.

In July 2023, Johnson & Johnson announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. through an exchange offer.

In May 2023, Stryker Corporation acquired Cerus Endovascular. The company is involved in the design, development, manufacture and supply of interventional neurovascular devices and delivery systems used by neuroradiologists for treating intracranial aneurysms.

Key Questions Answered in This Report

  • 1. What was the size of the global neurovascular devices market in 2023?
  • 2. What is the expected growth rate of the global neurovascular devices market during 2024-2032?
  • 3. What are the key factors driving the global neurovascular devices market?
  • 4. What has been the impact of COVID-19 on the global neurovascular devices market?
  • 5. What is the breakup of the global neurovascular devices market based on the product?
  • 6. What is the breakup of the global neurovascular devices market based on end user?
  • 7. What are the key regions in the global neurovascular devices market?
  • 8. Who are the key players/companies in the global neurovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cerebral Embolization and Aneurysm Coiling Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Embolic Coils
      • 6.1.2.2 Flow Diverters
      • 6.1.2.3 Liquid Embolic Agents
    • 6.1.3 Market Forecast
  • 6.2 Cerebral Angioplasty and Stenting Systems
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Carotid Artery Stents
      • 6.2.2.2 Embolic Protection Devices
    • 6.2.3 Market Forecast
  • 6.3 Neurothrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Clot Retrieval Devices
      • 6.3.2.2 Suction Devices
      • 6.3.2.3 Vascular Snares
    • 6.3.3 Market Forecast
  • 6.4 Support Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Micro Catheters
      • 6.4.2.2 Micro Guidewires
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aneurysm
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arteriovenous Malformation and Fistulas (AVM)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Stenosis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acandis GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Asahi Intecc Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Imperative Care Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Integer Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MicroPort Scientific Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Penumbra Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perflow Medical Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rapid Medical
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio